SensDx
Time 2022-07-31 15:52:36Web Name: SensDx
WebSite: http://www.sensdx.eu
ID:266186
Keywords:
SensDxDescription:
SensDx uses cookies to track visits to our website only, no personal information is collected.By continuing to use the site you are agreeing to our use of cookies. Understood European Union HomeProductsMobi SensDx ReaderFlu SensDx AssayTechnologyAbout usAchievementsAdvisory BoardImplemented projectsNewsContact PL EN HomeProductsMobi SensDx ReaderFlu SensDx AssayTechnologyAbout usAchievementsAdvisory BoardImplemented projectsNewsContact PL ENFast and precise flu test!
FluSensDx detects influenza viruses even at a very early stage of infection in the patient. It is a valuable source of medical information that provides a chance for effective implementation of therapy with neuraminidase.
High Sensitivity
SensDx tests provide high sensitivity, comparable to the RT-PCR reference method. As the only one on the market, unlike the so-called “lateral flow” tests, it enables the detection of pathogen presence at an early stage of infection.Simplicity and rapidity
SensDx tests are easy to use - the application guides the user step by step, which means that it can be done by anyone. No additional qualifications are required. The test result is obtained within 3-5 minutes.Digital precision
The test analyses digital data, which allows for high reliability and continuous monitoring of the quality of the test. The result obtained in digital form can be printed out, sent to a selected recipient or archived in the system. Together with the result, the recipient receives a quality monitoring report of the test.Our products are available across Poland!
We are growing! Our digital diagnostic platforms for influenza virus detection are now available in over 100 medical facilities across Poland! Meet our medical facilitiesOur products
SensDx is working on the technology of ultra-sensitive micorsensors, modified with biological molecules. The molecules on the electrode surface are selected by biotechnological methods. It allows you to identify unambiguously which bacteria or virus is the cause of infection or to determine the oncological marker, DNA or RNA.
Currently, works in the field of cardiology, oncology, urology and veterinary medicine are being carried out.
Available soon!
Multi SensDx - test for identification of upper respiratory tract infections causes
Multisensor is a rapid diagnostic test to identify the etiology of an upper respiratory tract infection that identifies more than one pathogen in a single sample. Proper diagnosis of the causes of the infection will allow for effective and precise therapy, which will reduce the unnecessary use of antibiotics in cases where the infection is viral.
News
SensDx is an Innovative Company in the Innovator of Mazovia competition!
05/11/2021We are awarded and honored in the Innovative Company category during the Final of the 13th edition of the Innovator Mazowsza competition for FluSensor SensDx – developing a solution for detecting the influenza virus at an early stage of infection!
Read moreWe got a self-test certification!
29/10/2021We are pleased to announce that from today it will be possible to use Flu SensDx at home!
Read moreGood Design 2020 New Technologies award for Flu SensDx
02/11/2020SensDx received the Good Design 2020New Technologies award for Flu SensDx – a mobile diagnostic platform for pathogen detection!
Read more Proceed to archiveVision
Our vision is to revolutionize medical diagnosis worldwide by providing effective, rapid and easy-to-use tests to detect pathogens causing specific diseases.
Mission
Our mission is to prevent the spreading of bacteria and viruses by detecting pathogens at an early stage of development.
Technology
The innovative solution combines a simple tool based on a fast, ultra-sensitive diagnostic test with a mobile application for easy result interpretation.
Tests
The test tools are placed inside specially-designed devices called Mobi (for individual patients) or Pro (for medical professionals)
Team
SensDX comprises of an interdisciplinary team of experts specialising in biotechnological, chemical, electrochemical and electronic sciences, IT, production automation and business, including IP protection, technology commercialisation, sales and marketing. We work in line with modern management methods, high quality standards and safety regulations.
Accomplishments
The dynamic growth of SensDx has been facilitated by funds obtained through a wide range of subsidies. While evaluating the SensDx applications, experts appreciated not only the technology, which will have a wide range of applications in telemedicine and diagnostics, but also the innovative functionality, huge commercialisation potential and business model, implemented consistently by SensDx.
Learn moreSensDx S.A.
District Court for the Capital City of Warsaw in Warsaw
XIII Commercial Department of the National Court Register
KRS: 0000740748
NIP: 5213679076
REGON: 147422840
Share capital: 100 000 zł (paid in full)
Office
ul. Postępu 14B, 02-676 Warszawa
Offices and laboratories
ul. Kampinoska 25, 80-180 Gdańsk
ul. Bierutowska 57-59, 51-317 Wrocław
(Wrocławski Park Biznesu 3)
ul. Nałęczowska 14, 20-701 Lublin
Mailing Address
ul. Kampinoska 25, 80-180 Gdańsk
office@sensdx.eu
International Sales & Distribution
sales@sensdx.eu
Click here for more information about international distribution
CEE Region Sales
Poland, Czech Republic, Slovakia, Hungary
+48 576 939 000
sales-cee@sensdx.eu
Media
+48 535 496 885
media@sensdx.eu
Accounting
invoices@sensdx.eu
Foreign currency accounts:
PLN: PL 72 1240 6410 1111 0010 6100 8930
EUR: PL 04 1240 1112 1978 0010 9610 3439
USD: PL 94 1240 1112 1787 0011 0139 2049
TAGS:SensDx
<<< Thank you for your visit >>>
Websites to related :
adsHot Websites